| Similar Articles |
|---|
 |
Salon.com
August 10, 2001
Flore de Preneuf |
"Palestinians are not afraid of death" Just a week before a deadly Jerusalem pizzeria bombing, the spiritual leader for Hamas told Salon how, by "protecting the dignity of his people," a suicide bomber "becomes a martyr"...   |
Salon.com
April 25, 2001
Suzy Hansen |
The assault on the USS Liberty Experts respond to new evidence that the deadly 1967 attack on a U.S. spy ship by Israeli forces was deliberate... |
Salon.com
December 8, 2001
Suzy Hansen |
Beyond tribalism Controversial Israeli historian Tom Segev says a new generation of Israelis is moving beyond Zionism -- but there will be no peace until old warriors Sharon and Arafat are gone... |
Salon.com
November 27, 2000
Flore de Preneuf |
Middle East meets Wild West With the crisis simmering and the death toll mounting in Israel, vigilante movements are brewing among Israelis and Palestinians alike... |
Salon.com
June 6, 2001
Flore de Preneuf |
Brinkmanship of blood Pushed to the edge by rage and revenge, Palestinians and Israelis stare into the abyss of war... |
The Motley Fool
May 26, 2010
Brian Orelli |
Is Johnson & Johnson a Buy? Let's see what it says to Congress first on safety issues. |
The Motley Fool
February 28, 2011
Brian Orelli |
Johnson & Johnson Parties Like It's 1982 The big pharma announced that it was recalling 667,632 packages of Sudafed tablets because the instructions contained a typo. |
Salon.com
September 11, 2001
Flore de Preneuf |
Rejoicing in the streets of Jenin While many Palestinians celebrate the attack on the U.S., Yasser Arafat denounces it as "unacceptable" and Israelis mourn... |
The Motley Fool
July 14, 2008
Brian Orelli |
Foolish Forecast: J&J Trudges Along In advance of earnings analysts wonder if Johnson & Johnson is a recovery story waiting to happen, or still stuck in a rut? |
The Motley Fool
August 14, 2007
Brian Orelli |
A No-Win Situation Johnson & Johnson is suing the beloved American Red Cross for trademark infringement. Johnson & Johnson just needs to walk a fine line between having its brand eroded by the Red Cross and having its brand eroded by a public relations nightmare. |
Salon.com
May 28, 2002
Marcy Spiegel Oster |
A settler's story My husband, children and I moved from Cleveland to the West Bank just before the latest intifada. We're told that we're the obstacle to peace -- but we don't see it that way... |
The Motley Fool
June 28, 2011
Eric Bleeker |
Johnson & Johnson Is Looking Abroad for Growth Where's Johnson & Johnson generating its sales? |
The Motley Fool
November 26, 2010
Brian Orelli |
Get It Together, Johnson & Johnson Another day, another recall. |
The Motley Fool
July 12, 2011
Todd Wenning |
What Does Johnson & Johnson Do With Its Free Cash? Johnson & Johnson appears to be making fair use of its free cash flow, and its well-covered dividend may be attractive to income-focused investors. |
Salon.com
October 23, 2000
Flore de Preneuf |
Peace? Please hold As the bloodbath rages in the Middle East, Ehud Barak calls for a "timeout" in the peace process... |
The Motley Fool
January 26, 2010
Brian Orelli |
Is the Best of Johnson & Johnson Behind It? Johnson & Johnson announces that its sales fell for the first time in 76 years. |
Salon.com
September 12, 2002
Suzy Hansen |
Why terrorism works Alan Dershowitz says the world community opened the door to al-Qaida by rewarding Palestinian terrorists -- and makes the case for national I.D. cards and torture. |
BusinessWeek
July 2, 2007
Neal Sandler |
Israel: A Hotbed Of...Investment Amid tightened security, companies in Israel are thriving at home - and expanding abroad. |
Salon.com
October 30, 2001
Suzy Hansen |
A Jew in the mosque A self-described "average Israeli" talks about his daring journey to pray with the Holy Land's Muslims and Christians -- and why Arafat cannot head a Palestinian state... |
The Motley Fool
July 31, 2007
Nathan Parmelee |
Break Out the Band-Aids at J&J Johnson & Johnson is making some deep cuts to change its cost structure. Shareholders haven't had much to cheer about lately here, but the potential benefits from this move could help cure some of the current softness in the business. |
The Motley Fool
January 18, 2012 |
What Johnson & Johnson Does With Its Cash Over the last five years, Johnson & Johnson shares returned 14%, which drops to -3% without dividends -- not a bad boost to top off otherwise lowly share performance. |
IEEE Spectrum
May 2006
Lauren Aaronson |
Parallel Processor How IBM engineer Sandra Johnson contributes to her field, her business, and the community. |
The Motley Fool
August 27, 2010
Brian Orelli |
A Recall a Week, That's All We Ask For Johnson & Johnson, apparently that's too much. |
The Motley Fool
June 15, 2011
Brian Orelli |
Johnson & Johnson Is a Quitter The diversified health-care giant has decided to exit the drug-eluting stent market. |
The Motley Fool
June 4, 2010
Brian Orelli |
Out With Drugs, in With Medical Devices Johnson & Johnson's movement in medical devices and diagnostics is headed in the right direction, but whether Johnson & Johnson is a buy depends a lot on how it handles its current drug problem. Unfortunately investors can't have one without the other. |
Sports Illustrated
April 11, 2001
E.M. Swift |
Setting the record straight Skier Bill Johnson reigned at more than just Sarajevo... |
The Motley Fool
May 28, 2010
Brian Orelli |
How Much Is This Going to Cost J&J? Investors need an answer from Johnson & Johnson about low-quality drugs that were recalled. Is the problem systemic, and if so, how much will it cost the company to fix the problem? |
Sports Central
October 8, 2011
David Exum |
Don't Count Out Jimmie Johnson I don't think I'll ever understand why some race fans can't embrace five-time and defending NASCAR Sprint Cup champion Jimmie Johnson. |
Salon.com
January 4, 2001
Michael Adams |
The fraud of American "peacemaking" Clinton is just the latest U.S. leader whose one-sided support for Israel has doomed the region to bloodshed... |
Salon.com
June 12, 2002
Suzy Hansen |
Six days that shook the world An Israeli historian talks about the weeklong war that shaped the modern Middle East and still fuels the Arab-Israeli conflict. |
The Motley Fool
February 24, 2011
Brian Orelli |
Abbott: 1, Johnson & Johnson: 0 -- For Now Abbott Labs got a ruling overturned yesterday that would have cost the company $1.8 billion, yet investors let shares slip down 1%. |
The Motley Fool
December 1, 2010
Brian Orelli |
We're Still Buying. Probably. Despite manufacturing problems, Johnson &Johnson continues with its purchase of Crucell. |
The Motley Fool
March 17, 2009
Brian Orelli |
Stent Wars, Episode III: The Rise of Xience V Johnson & Johnson lose the lead in the stent war race, but this is a marathon, not a footrace. |
The Motley Fool
June 25, 2010
Brian Orelli |
The Joys of Being Large and Diversified Johnson & Johnson's plant closure is a rounding error. |
The Motley Fool
May 20, 2009
Brian Orelli |
Johnson & Johnson Tries to Pull a Travolta Johnson & Johnson seems to be making a comeback, after its drug-eluting stent market share fell precipitously to just 15% in the first quarter. |
The Motley Fool
October 12, 2004
Alyce Lomax |
Take It Away, J&J Should investors sweat a coming slowdown in growth for pharmaceutical and consumer products giant Johnson & Johnson? |
The Motley Fool
September 30, 2009
Brian Orelli |
Boston Scientific Pays Up And Johnson & Johnson reaps the rewards. |
Salon.com
August 26, 2000
Cathy Young |
They're no angels Is women's basketball a kinder, gentler game? The WNBA shows that women aren't nicer than men -- but they aren't better, either. |
The Motley Fool
October 19, 2011
Brian Orelli |
Not the Best Quarter, but... There's little reason to worry about Johnson & Johnson. |
The Motley Fool
July 19, 2011
Brian Orelli |
J&J: Better, but Not Best A decent-looking quarter, but a turnaround could still take awhile. |
Sports Central
July 30, 2010
Jeffrey Boswell |
Sports Q&A: Jimmy Johnson's Market Penetration What should we make of Johnson's status as a celebrity endorser and reality star? |
The Motley Fool
September 14, 2009
Brian Orelli |
The Clock Is Ticking for Elan Elan is getting closer to the Sept. 26 deadline to fix its contract with Johnson & Johnson. If it doesn't, Biogen Idec has the right to take full control of Elan's and Biogen's multiple-sclerosis drug, Tysabri. |
Sports Central
March 16, 2015
Jeff Kallman |
Alex Johnson, RIP: The Fires Within To hear the Whitey Herzog say it, Johnson -- who died February 28 at 72, after a battle with cancer -- was anything but a handful, once you played things straight with him. |
Salon.com
November 6, 2001
Gary Kamiya |
It's time for U.S. to broker Mideast peace, says Palestinian leader Hanan Mikhail-Ashrawi tells Osama bin Laden he does "not have the right to use" the Palestinian plight "for your ends"... |
Outside
February 2002
Bill Donahue |
End of the Run In Sarajevo, Bill Johnson won America's first Olympic gold medal in the downhill with an astonishing kamikaze performance. Now, in the wake of a comeback attempt that almost killed him, skiing's crash-course survivor struggles with the consequences of a life lived too fast... |
Sports Central
July 18, 2007
Ricky Dimon |
Bracing For the Calvin Johnson Blastoff It's not Johnson's fault that he was not the top pick. |
The Motley Fool
January 23, 2008
Brian Orelli |
A Dose of Stability From J&J Top-line growth looked great at Johnson & Johnson -- more than 16% year over year -- but when you dove a little further into the earnings, growth wasn't quite that stellar. |
The Motley Fool
February 22, 2010
Brian Orelli |
So Long, See You in Arbitration After another rejection, Johnson & Johnson and Basilea call it quits. |
Salon.com
April 19, 2001
Ben Barber |
Dragged back into the fight As the confrontation between Israel and the Palestinians threatens to engulf the region, how long can the Bush administration stay out of the fray? |
The Motley Fool
December 17, 2009
Brian Orelli |
This Acquisition Hears, Smells, and Tastes Soooo Good Johnson & Johnson picks up an ear, nose, and throat medical device maker. |
